Impact of antiretroviral treatment on AIDS dementia: a longitudinal prospective event-related potential study

Article Abstract:

Zidovudine may delay the progression of dementia in AIDS patients. Researchers used an eye examination called event-related potentials (ERP) to measure delays in reaction time in 98 HIV patients indicating possible intellectual deficits. About half of the patients were taking zidovudine and the rest received no treatment. The eye exam was given three times over a two-year period. Patients on zidovudine had faster reaction times than those receiving no treatment. This was true regardless of which stage of the infection the patient was in.

Evaluation, Prevention, Zidovudine, AIDS dementia, AIDS dementia complex

---

Application of an expert system in the management of HIV-infected patients

Article Abstract:

An expert system that considers the genetic characteristics of the infecting virus may improve prescribing decisions in the treatment of patients with HIV infection. After the patient's HIV RNA sequence data are entered into the computer system, optimal drug regimens are recommended.

United States, Health aspects, Statistical Data Included, Medicine, Information management, Expert systems, Dosage and administration, Antiviral agents

---

Similar abstracts:

• Abstracts: Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial
• Abstracts: Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial
• Abstracts: Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE. part 2
• Abstracts: Gene therapy - a novel form of drug delivery. Muscle-mediated gene therapy

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.